linaclotide – Reflux Care of New York http://refluxny.com Long Island's Leading Center for Gastroesophageal Reflux Disease , Laryngopharyngeal Reflux, Eosinophilic Esophagitis and Irritable Bowel Syndrome Wed, 18 Dec 2019 05:26:05 +0000 en-US hourly 1 Research Performed at Progressive Gastroenterology Leads to FDA Approval of Linzess (Linaclotide) for the Treatment of Irritable Bowel Syndrome and Chronic Constipation http://refluxny.com/constipation-irritable-bowel-syndrome-linzess/ http://refluxny.com/constipation-irritable-bowel-syndrome-linzess/#respond Sun, 04 Nov 2012 21:40:49 +0000 http://refluxny.com/?p=48 Linzess (Linaclotide) has been shown to be safe and effective for Constipation Predominant Irritable Bowel Syndrome (IBS-C) and Chronic Constipation (CC).

The post Research Performed at Progressive Gastroenterology Leads to FDA Approval of Linzess (Linaclotide) for the Treatment of Irritable Bowel Syndrome and Chronic Constipation appeared first on Reflux Care of New York.

]]> http://refluxny.com/constipation-irritable-bowel-syndrome-linzess/feed/ 0